Palatin Technologies Inc (PTN) stock
PTNNasdaqPharmaceutical PreparationsFiscal year ends June 30
$6.23−0.34 (-5.18%)
Close on Nov 13, 2026Market cap $11.10MP/E –Yield –
Palatin Technologies ebitda
EBITDA is earnings before interest, taxes, depreciation and amortization, a rough measure of cash profit from operations.
Palatin Technologies's ebitda for the twelve months ending Jun 30, 2026 was -$8.61M. For fiscal 2026 it was -$8.61M. The highest annual figure on record is $35.80M in fiscal 2019.
Annual ebitda
| Period | Period end | Value | Change |
|---|---|---|---|
| FY2026 | Jun 30, 2026 | -$8.61M | – |
| FY2025 | Jun 30, 2025 | -$17.20M | – |
| FY2024 | Jun 30, 2024 | -$22.16M | – |
| FY2023 | Jun 30, 2023 | -$32.17M | – |
| FY2022 | Jun 30, 2022 | -$36.46M | – |
| FY2021 | Jun 30, 2021 | -$33.33M | – |
| FY2020 | Jun 30, 2020 | -$23.54M | -165.8% |
| FY2019 | Jun 30, 2019 | $35.80M | +37.8% |
| FY2018 | Jun 30, 2018 | $25.98M | +0.1% |
| FY2017 | Jun 30, 2017 | $25.96M | – |
| FY2016 | Jun 30, 2016 | -$49.21M | – |
| FY2015 | Jun 30, 2015 | -$17.17M | – |
| FY2014 | Jun 30, 2014 | -$15.68M | – |
| FY2013 | Jun 30, 2013 | -$15.47M | – |
| FY2012 | Jun 30, 2012 | -$17.84M | – |
| FY2011 | Jun 30, 2011 | -$12.52M | – |
| FY2010 | Jun 30, 2010 | -$1.74M | – |
Quarterly ebitda
Change is against the same quarter a year earlier.
Periods
| Period | Period end | Value | Change |
|---|---|---|---|
| Q4 FY2026CQ2 2026 | Jun 30, 2026 | -$4.40M | – |
| Q3 FY2026CQ1 2026 | Mar 31, 2026 | -$1.56M | – |
| Q2 FY2026CQ4 2025 | Dec 31, 2025 | -$7.31M | – |
| Q1 FY2026CQ3 2025 | Sep 30, 2025 | $4.68M | – |
| Q4 FY2025CQ2 2025 | Jun 30, 2025 | -$2.22M | – |
| Q3 FY2025CQ1 2025 | Mar 31, 2025 | -$4.76M | – |
| Q2 FY2025CQ4 2024 | Dec 31, 2024 | -$2.54M | – |
| Q1 FY2025CQ3 2024 | Sep 30, 2024 | -$7.68M | – |
| Q4 FY2024CQ2 2024 | Jun 30, 2024 | -$8.26M | – |
| Q4 FY2023CQ2 2023 | Jun 30, 2023 | -$10.74M | – |
| Q3 FY2023CQ1 2023 | Mar 31, 2023 | -$7.22M | – |
| Q4 FY2022CQ2 2022 | Jun 30, 2022 | -$13.06M | – |
| Q3 FY2022CQ1 2022 | Mar 31, 2022 | -$7.78M | – |
| Q2 FY2022CQ4 2021 | Dec 31, 2021 | -$8.42M | – |
| Q1 FY2022CQ3 2021 | Sep 30, 2021 | -$7.20M | – |
| Q4 FY2021CQ2 2021 | Jun 30, 2021 | -$13.69M | – |
| Q3 FY2021CQ1 2021 | Mar 31, 2021 | -$6.47M | – |
| Q2 FY2021CQ4 2020 | Dec 31, 2020 | -$9.24M | – |
| Q1 FY2021CQ3 2020 | Sep 30, 2020 | -$3.93M | – |
| Q4 FY2020CQ2 2020 | Jun 30, 2020 | -$7.38M | -114.1% |
| Q3 FY2020CQ1 2020 | Mar 31, 2020 | -$5.70M | – |
| Q2 FY2020CQ4 2019 | Dec 31, 2019 | -$5.62M | – |
| Q1 FY2020CQ3 2019 | Sep 30, 2019 | -$4.84M | – |
| Q4 FY2019CQ2 2019 | Jun 30, 2019 | $52.20M | +325.0% |
| Q3 FY2019CQ1 2019 | Mar 31, 2019 | -$5.75M | – |
| Q2 FY2019CQ4 2018 | Dec 31, 2018 | -$5.04M | -270.4% |
| Q1 FY2019CQ3 2018 | Sep 30, 2018 | -$5.61M | -149.9% |
| Q4 FY2018CQ2 2018 | Jun 30, 2018 | $12.28M | -75.8% |
| Q3 FY2018CQ1 2018 | Mar 31, 2018 | -$503.76K | – |
| Q2 FY2018CQ4 2017 | Dec 31, 2017 | $2.96M | – |
| Q1 FY2018CQ3 2017 | Sep 30, 2017 | $11.25M | – |
| Q4 FY2017CQ2 2017 | Jun 30, 2017 | $50.83M | – |
| Q3 FY2017CQ1 2017 | Mar 31, 2017 | -$3.00M | – |
| Q2 FY2017CQ4 2016 | Dec 31, 2016 | -$9.43M | – |
| Q1 FY2017CQ3 2016 | Sep 30, 2016 | -$12.43M | – |
| Q4 FY2016CQ2 2016 | Jun 30, 2016 | -$12.73M | – |
| Q3 FY2016CQ1 2016 | Mar 31, 2016 | -$12.07M | – |
See a number that looks wrong?